Correlation Between NYSE Composite and Seelos Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Seelos Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Seelos Therapeutics.
Diversification Opportunities for NYSE Composite and Seelos Therapeutics
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Seelos is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Seelos Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Seelos Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.06 times more return on investment than Seelos Therapeutics. However, NYSE Composite is 17.15 times less risky than Seelos Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 1,544,050 in NYSE Composite on September 1, 2024 and sell it today you would earn a total of 483,154 from holding NYSE Composite or generate 31.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 97.4% |
| Values | Daily Returns |
NYSE Composite vs. Seelos Therapeutics
Performance |
| Timeline |
NYSE Composite and Seelos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Seelos Therapeutics
Pair trading matchups for Seelos Therapeutics
Pair Trading with NYSE Composite and Seelos Therapeutics
The main advantage of trading using opposite NYSE Composite and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.| NYSE Composite vs. Acumen Pharmaceuticals | NYSE Composite vs. Mind Medicine | NYSE Composite vs. NL Industries | NYSE Composite vs. Ecovyst |
| Seelos Therapeutics vs. ATAI Life Sciences | Seelos Therapeutics vs. Mind Medicine | Seelos Therapeutics vs. GH Research PLC | Seelos Therapeutics vs. Cybin Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |